AI assistant
UNITED THERAPEUTICS Corp — Director's Dealing 2017
Jun 9, 2017
30320_dirs_2017-06-09_6759e604-4cf7-4331-abff-e898b814f410.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: UNITED THERAPEUTICS Corp (UTHR)
CIK: 0001082554
Period of Report: 2017-06-08
Reporting Person: ROTHBLATT MARTINE A (Director, Chairman & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-06-08 | Common Stock | M | 1240 | $30.75 | Acquired | 1380 | Direct |
| 2017-06-08 | Common Stock | M | 937 | $30.75 | Acquired | 660303 | Indirect |
| 2017-06-08 | Common Stock | S | 400 | $128.9625 | Disposed | 980 | Direct |
| 2017-06-08 | Common Stock | S | 740 | $129.808 | Disposed | 240 | Direct |
| 2017-06-08 | Common Stock | S | 100 | $130.56 | Disposed | 140 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-06-08 | Stock Options | $30.75 | M | 1240 | Disposed | 2017-12-31 | Common Stock (1240) | Direct |
| 2017-06-08 | Stock Options | $30.75 | M | 937 | Disposed | 2017-12-31 | Common Stock (937) | Direct |
Footnotes
F1: This exercise of stock options and corresponding sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. The transaction was structured as a broker-assisted cashless exercise, such that the number of shares sold was limited to a sufficient number to cover the exercise price of the options and anticipated taxes. The remaining shares are held by a trust beneficially owned by the reporting person.
F2: Exercise price and number of shares/awards has been adjusted to reflect the issuer's two-for-one stock split on September 22, 2009.
F3: This transaction was executed in multiple trades at prices ranging from $128.37 to $129.23. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F4: This transaction was executed in multiple trades at prices ranging from $129.41 $130.16. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.